ABBV Dividend History & Yield
AbbVie Inc. · NYSE
Upcoming dividend payments
| Ex-date | Pay date | Per share | Per 100 shares | Status |
|---|---|---|---|---|
| Wed, Oct 14, 2026 (in 36 days) | Oct 28, 2026 | $1.73 | $173.00 | Estimated |
| Wed, Jan 13, 2027 (in 127 days) | Jan 27, 2027 | $1.73 | $173.00 | Estimated |
| Wed, Apr 14, 2027 (in 218 days) | Apr 28, 2027 | $1.73 | $173.00 | Estimated |
| Wed, Jul 14, 2027 (in 309 days) | Jul 28, 2027 | $1.73 | $173.00 | Estimated |
Estimated dates and amounts are projected from ABBV's recent payment pattern and will be replaced by declared figures when the company announces them. Total over the next 12 months: about $6.92 per share.
Dividend payment history
Last 40 payments per share. RegularSpecial
Annual dividends per share
How much ABBV do you need for monthly income?
| Target income | Shares needed | Capital at today's price | Per year |
|---|---|---|---|
| $100 / month | 174 | $43,155 | $1,200 |
| $500 / month | 868 | $215,775 | $6,000 |
| $1,000 / month | 1,735 | $431,549 | $12,000 |
Based on the forward yield of 2.78%. $10,000 in ABBV would currently pay about $278 a year ($23 a month on average). Model reinvestment and growth →
ABBV dividend history
| Ex-date | Pay date | Amount | Change |
|---|---|---|---|
| Jul 15, 2026 | — | $1.73 | +0.0% |
| Apr 15, 2026 | — | $1.73 | +0.0% |
| Jan 16, 2026 | — | $1.73 | +5.5% |
| Oct 15, 2025 | — | $1.64 | +0.0% |
| Jul 15, 2025 | — | $1.64 | +0.0% |
| Apr 15, 2025 | — | $1.64 | +0.0% |
| Jan 15, 2025 | — | $1.64 | +5.8% |
| Oct 15, 2024 | — | $1.55 | +0.0% |
| Jul 15, 2024 | — | $1.55 | +0.0% |
| Apr 12, 2024 | — | $1.55 | +0.0% |
| Jan 12, 2024 | — | $1.55 | +4.7% |
| Oct 12, 2023 | — | $1.48 | +0.0% |
| Jul 13, 2023 | — | $1.48 | +0.0% |
| Apr 13, 2023 | — | $1.48 | +0.0% |
| Jan 12, 2023 | — | $1.48 | +5.0% |
| Oct 13, 2022 | — | $1.41 | +0.0% |
| Jul 14, 2022 | — | $1.41 | +0.0% |
| Apr 13, 2022 | — | $1.41 | +0.0% |
| Jan 13, 2022 | — | $1.41 | +8.5% |
| Oct 14, 2021 | — | $1.30 | +0.0% |
| Jul 14, 2021 | — | $1.30 | +0.0% |
| Apr 14, 2021 | — | $1.30 | +0.0% |
| Jan 14, 2021 | — | $1.30 | +10.2% |
| Oct 14, 2020 | — | $1.18 | +0.0% |
| Jul 14, 2020 | — | $1.18 | +0.0% |
| Apr 14, 2020 | — | $1.18 | +0.0% |
| Jan 14, 2020 | — | $1.18 | +10.3% |
| Oct 11, 2019 | — | $1.07 | +0.0% |
| Jul 12, 2019 | — | $1.07 | +0.0% |
| Apr 12, 2019 | — | $1.07 | +0.0% |
| Jan 14, 2019 | — | $1.07 | +11.5% |
| Oct 12, 2018 | — | $0.96 | +0.0% |
| Jul 12, 2018 | — | $0.96 | +0.0% |
| Apr 12, 2018 | — | $0.96 | +35.2% |
| Jan 11, 2018 | — | $0.71 | +10.9% |
| Oct 12, 2017 | — | $0.64 | +0.0% |
| Jul 12, 2017 | — | $0.64 | +0.0% |
| Apr 11, 2017 | — | $0.64 | +0.0% |
| Jan 11, 2017 | — | $0.64 | +12.3% |
| Oct 12, 2016 | — | $0.57 | +0.0% |
| Jul 13, 2016 | — | $0.57 | +0.0% |
| Apr 13, 2016 | — | $0.57 | +0.0% |
| Jan 13, 2016 | — | $0.57 | +11.8% |
| Oct 13, 2015 | — | $0.51 | +0.0% |
| Jul 13, 2015 | — | $0.51 | +0.0% |
| Apr 13, 2015 | — | $0.51 | +4.1% |
| Jan 13, 2015 | — | $0.49 | +16.7% |
| Oct 10, 2014 | — | $0.42 | +0.0% |
| Jul 11, 2014 | — | $0.42 | +0.0% |
| Apr 11, 2014 | — | $0.42 | +5.0% |
| Jan 13, 2014 | — | $0.40 | +0.0% |
| Oct 10, 2013 | — | $0.40 | +0.0% |
| Jul 11, 2013 | — | $0.40 | +0.0% |
| Apr 11, 2013 | — | $0.40 | +0.0% |
| Jan 11, 2013 | — | $0.40 | — |
Payout risk check
ABBV scores 20/100 on our yield-trap heuristic (low risk).
1 warning flag raised:
- Payout ratio above 100% of earnings
This is a rule-based screen computed from public data, not a rating or a recommendation. Read our guide to yield traps for what the signals mean.
About AbbVie Inc.
AbbVie Inc., a research-based biopharmaceutical company, engages in the research and development, manufacturing, commercializing, and sale of medicines and therapies worldwide. The company offers Skyrizi to treat autoimmune diseases; Rinvoq to treat inflammatory diseases; Imbruvica for the treatment of adult patients with blood cancers; Venclexta to treat blood cancers; Elahere to treat various cancer; and Epkinly to treat lymphoma; and Emrelis for the treatment of lung cancer.
Sector: Healthcare. Industry: Drug Manufacturers - General. First dividend on our records: Jan 11, 2013. 55 payments tracked.
ABBV dividend FAQ
When is ABBV's next ex-dividend date?
ABBV's next ex-dividend date is Oct 14, 2026 (in 36 days, estimated from its quarterly schedule). You must own the shares before that date to receive the payment of about $1.73 per share, expected on Oct 28, 2026.
How often does ABBV pay dividends?
ABBV pays dividends every quarter, 4 times a year. The most recent payment was $1.73 per share with an ex-date of Jul 15, 2026.
What is ABBV's dividend yield?
ABBV's trailing 12-month dividend yield is 2.74%, based on $6.83 per share paid over the last year and a share price of $248.86. The forward yield, using the indicated annual rate of $6.92 per share, is 2.78%.
How much does ABBV pay per share?
ABBV pays about $1.73 per share each quarter, which works out to roughly $6.92 per share a year. 100 shares would collect about $692.00 a year.
Has ABBV grown or cut its dividend?
ABBV has raised its annual dividend for 12 consecutive years. Over the last 5 years the regular payout has grown at 6.1% a year (+5.6% over the last year). There has been no cut to a regular payment in the last 5 years.
How many shares of ABBV do I need to earn $100 a month?
At the current forward yield of 2.78%, you would need about 174 shares of ABBV (roughly $43,155 invested at today's price) to collect $1,200 a year, or $100 a month on average, before taxes. Payments arrive every quarter, so the monthly figure is an average.
Similar dividend stocks
| Symbol | Type | Price | TTM yield | Annual / share | Frequency | Next ex-date | Trend |
|---|---|---|---|---|---|---|---|
| LLYEli Lilly and Company | Stock | $1,123.91 | 0.60% | $6.92 | Quarterly | Nov 13 Est. | |
| JNJJohnson & Johnson | Stock | $269.17 | 1.96% | $5.36 | Quarterly | Nov 24 Est. | |
| MRKMerck & Co., Inc. | Stock | $148.46 | 2.26% | $3.40 | Quarterly | Sep 15 Declared | |
| UNHUnitedHealth Group Incorporated | Stock | $400.84 | 2.23% | $9.28 | Quarterly | Sep 14 Declared | |
| NVSNovartis AG | Stock | $137.70 | 3.47% | $4.773 | Annual | Mar 11 Est. | |
| AZNAstraZeneca PLC | Stock | $160.04 | 1.35% | $4.306 | Semi-annual | Feb 18 Est. | |
| TMOThermo Fisher Scientific Inc. | Stock | $603.02 | 0.30% | $1.88 | Quarterly | Sep 15 Declared | |
| AMGNAmgen Inc. | Stock | $393.17 | 2.53% | $10.08 | Quarterly | Nov 20 Est. |